The over-expression of NRP1 enhances tumour growth, correlates with invasive growth and is associated with poor prognosis in gastrointestinal tract, prostate, lung and ovarian tumours as well as gliomas, osteosarcomas and melanomas 15,20,21. This evidence concerns the gene NRP1 and glioma.